Info graphics on the public disclosures within the scope of the Transparency Code
54 pharmaceutical companies, representing 75% of the German market for ethical drugs, published their 2016 payments to physicians, healthcare professionals, medical organizations and institutions.
The collaboration between pharmaceutical companies and scientific medicine is a decisive part for the welfare of the patient. The required transparency creates the preconditions for a good relationship between physicians and patients: It creates trust and combats mistrust.
Selected Media Response to the Transparency Code
The Communication regarding the publication of the financial contribution physicians receive from pharmaceutical companies in June and July 2017 shows that there is now a factual debate appointed on the contributions of the pharmaceutical companies to physicians
Transparency creates trust and combats mistrust!
- The collaboration between pharma companies and members of the medical profession is vital and necessary.
- It promotes patient well-being and the continuous improvement of his medical care.
- That is why there are explicit provisions, laws and codes of conduct that clearly regulate collaboration for both sides.
- Through transparency in collaboration, the appearance of conflicts of interest can be prevented at the onset.